Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measurable Residual Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04526288
What this trial is testing

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
Fred Hutchinson Cancer Center 1
Not applicableLooking for participantsNCT06111105
What this trial is testing

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IIILiver Metastasis Colon Cancer
Claus Lindbjerg Andersen 590
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Not applicableUnknownNCT05697913
What this trial is testing

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma
Hospital Galdakao-Usansolo 66
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT03665480
What this trial is testing

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Who this might be right for
Granulocyte Colony-stimulating FactorMinimal Residual DiseaseAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 122
Not applicableUnknownNCT05371873
What this trial is testing

Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 250
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT07821333
What this trial is testing

Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III

Who this might be right for
Colorectal Neoplasms MalignantMinimal Residual DiseaseCirculating Tumor Cell
Fundación para la Investigación del Hospital Clínico de Valencia 45
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Early research (Phase 1)Study completedNCT01757639
What this trial is testing

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Study completedNCT00179829
What this trial is testing

WT1 for the Detection of Minimal Residual Disease

Who this might be right for
LeukemiaCancer
Ann & Robert H Lurie Children's Hospital of Chicago 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07257380
What this trial is testing

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital 90
Not applicableStudy completedNCT02339805
What this trial is testing

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

Who this might be right for
Non Hodgkin Lymphoma
Centre Henri Becquerel 30
Testing effectiveness (Phase 2)UnknownNCT01665001
What this trial is testing

Personalized Therapy of Precursor Lymphoid Neoplasms

Who this might be right for
Precursor Lymphoid Neoplasms
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 200
Not applicableEnded earlyNCT04545333
What this trial is testing

The clonoSEQ® Watch Registry

Who this might be right for
Acute Lymphoblastic Leukemia, Adult B-CellChronic Lymphocytic LeukemiaMultiple Myeloma+1 more
Adaptive Biotechnologies 465
Not applicableStudy completedNCT00819143
What this trial is testing

Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease

Who this might be right for
Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT00923013
What this trial is testing

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

Who this might be right for
Hairy Cell Leukemia
National Cancer Institute (NCI) 175
Early research (Phase 1)Not Yet RecruitingNCT07443137
What this trial is testing

CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

Who this might be right for
Large-cell Lymphoma
Stanford University 20
Testing effectiveness (Phase 2)WithdrawnNCT03760445
What this trial is testing

HDM201 Added to CT in R/R or Newly Diagnosed AML

Who this might be right for
Leukemia, Myeloid, Acute
Novartis Pharmaceuticals
Next Page